Table 3.
Fibronectin
|
Laminin
|
Collagen I
|
Collagen IV
|
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
BM | B | E | BM | B | E | BM | B | E | BM | B | E | |
Normal | ++++ | − | +++ | + | − | + | ++++ | ++++ | +++ | + | − | + |
MGUS | ++++ | − | +++ | + | − | + | ++++ | ++++ | +++ | +++ | − | ++ |
MM (lowb) | ++++ | − | +++ | + | − | + | ++++ | ++++ | +++ | +++ | − | ++ |
MM (midc) | ++ | − | +++ | + | − | + | +++ | ++++ | +++ | +++ | − | ++ |
MM (highd) | ++ | − | ++ | + | − | + | ++ | ++++ | ++ | ++++ | − | +++ |
Scores were based on the expression of ECM proteins through the entire length of the core biopsy.
Low plasmacytosis (<20%).
Medium plasmacytosis (40–50%).
High plasmacytosis (>80%).
++++, very strong expression; +++, strong expression; ++, moderate expression; +, weak expression; −, negative.
ECM, extracellular matrix; BM, bone marrow; B, bone; E, endosteum; MGUS, monoclonal gammopathy of undetermined significance; MM, multiple myeloma.